Market Research Hub

Global Subcutaneous Immunoglobulin Market Witnessed to Gain Substantial Revenue and Notable CAGR of 14% Through 2024

Key companies profiled in the report include Grifols S.A., CSL Behring LLC, Shire Plc., Biotest AG, Kedrion S.p.A., Octapharma AG, Baxalta Incorporated and Talecris Biotherapeutics, Inc.


Albany, NY -- (SBWIRE) -- 09/15/2017 -- According to a recent report, global subcutaneous immunoglobulin market is likely to present an opportunity-filled landscape for new players in the coming years. At present, the market is driven by a number of factors such as such as growing use of immunoglobulins in primary immunodeficiency disorders and widespread opportunities for immunoglobulins in the treatment of secondary immunodeficiency diseases such as AIDS are responsible for rapid growth. Market Research Hub (MRH) has broadcasted this 145-pages fresh study to its wide online repository, which is titled as "Subcutaneous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016-2024", which offers precise market overview covering current market scenario along with key highlights to its growth prospects for the period 2016 to 2024.

Request Free Sample Report:

Immunoglobulins are unique biologic medicines which can be either infused or injected to treat rare, chronic, life-threatening and genetic diseases. Subcutaneous immunoglobulin (SCIg) is a solution of human plasma proteins and in particular IgG antibodies with a broad spectrum of antibody activity. SCIg is used for patients who need replacement of antibodies. In SCIG, immunoglobulin is delivered by a needle into the fatty tissues under the skin, where it enters the circulation slowly over a few days.

In the first part, the report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. Geographically, the report studies the market in different regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Apart from that, the market has been analyzed on the basis of applications and various end-users. Moreover, market-related factors such as technological developments, product innovation, expansion of healthcare infrastructure facilities around the world, and historical year-on-year growth have been taken into consideration while estimating the market size. As per the key findings, the subcutaneous immunoglobulin market will expand at a CAGR of 14.0% over the forecast period between 2016 and 2024. Growing at this pace, the market, in terms of revenue is projected to rise to US$8,831.3 Mn by 2024 which had a valuation of US$2,762.2 Mn in 2015.

By application, it covers Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases. In between, primary immunodeficiency diseases (PIDD) accounted for maximum share of the global subcutaneous immunoglobulin market in 2015 and is expected to dominate the market in the coming years as well. Primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are defective. Therefore, it requires subcutaneous immunoglobulin medicines.

Browse Full Report with TOC -

In terms of end users, the subcutaneous immunoglobulin market is segmented into hospitals, home care and clinics. Through the geographical analysis, North America dominated the subcutaneous immunoglobulin market in terms of revenue in 2015 and is anticipated to retain its leading position until the end of 2024.

Further, the research finds that the global subcutaneous immunoglobulin market is categorized by the existence of a number of players. Key players profiled in the report include CSL Behring LLC, Shire Plc., Biotest AG, Baxalta Incorporated, Kedrion S.p.A., Grifols S.A., Octapharma AG and Talecris Biotherapeutics, Inc.

Enquire about this Report -

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at -